Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
6.25
+0.26 (4.34%)
Dec 20, 2024, 4:00 PM EST - Market closed

Design Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
58
Market Cap
353.88M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020226.00K-608.00K-72.90%
Dec 31, 2019834.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AngioDynamics 292.73M
Valneva SE 176.82M
Kamada 158.38M
Spok Holdings 137.71M
NeuroPace 76.45M
Aquestive Therapeutics 58.90M
Absci 4.21M
Prime Medicine 800.00K
Revenue Rankings